Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Breast Neoplasms 117Triple Negative Breast Neoplasms 45Neoplasm Metastasis 11Pancreatic Neoplasms 8Inflammatory Breast Neoplasms 7Breast Neoplasms, Male 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 4Neoplasms 4Lung Neoplasms 4Carcinoma, Ductal, Breast 4Sarcoma 3Prostatic Neoplasms 3Lymphoma, Non-Hodgkin 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Advanced Breast Cancer 2Thrombocytosis 1Stages II-III Breast Cancer 1Primary Myelofibrosis 1

Interventions

Taxes 1Paclitaxel 1Lapatinib 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × Albumin-Bound Paclitaxel × Breast × Clear all
NCT00313599 2014-07-02

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

University of California, San Francisco

Phase 1 Completed
28 enrolled
BreastCNSGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Dysgerminoma, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡